Prevalence of COVID-19 in End Stage Renal Disease Patients on Hemodialysis & Dialysis Providers During SARs-Cov-19 spike in Pakistan.
DOI:
https://doi.org/10.59058/jaimc.v21i2.120Keywords:
COVID-19, End Stage Renal Disease, Hemodialysis, ESRDAbstract
The global pandemic of coronavirus disease 2019 (COVID-19) poses a significant threat to both hemodialysis staff and patients. However, the prevalence of COVID-19 among asymptomatic end-stage renal disease (ESRD) patients on chronic hemodialysis (MHD) and healthcare staff including nurses and technicians in dialysis unit remains uncertain. Given that hemodialysis patients and dialysis nurses are particularly prone in congregate settings, this research aimed to examine the prevalence of COVID-19 in two hemodialysis units at Jinnah Hospital, Lahore, Pakistan. This cross-sectional study involved the participation of 198 maintenance hemodialysis patients with end-stage renal disease (ESRD) and 83 dialysis staff members. These patients or staff members did not have any symptoms at the time of testing. Testing was conducted using qualitative reverse transcription-polymerase chain reaction (RT-PCR) on nasal & pharyngeal swabs collected from June 18th to June 23rd, 2020.
Out of the total participants, 45 out of 198 dialysis patients (22.7%) and 10 out of 83 dialysis staff members (12%) were found to be positive for COVID-19. The overall prevalence of COVID-19, combining patients and staff, was 19.5% (55 out of 281). The mortality rate among the infected patients was 6.6% (3 out of 45). To conclude, the findings of this study demonstrate a significant prevalence of SARS-CoV-2 among hemodialysis staff and patients in Lahore, Pakistan.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Sidra Cheema, Hozaifa Habib, Manal Cheema, Samreen Gilani, Muhammad Asad Saeed, Shafiq Cheema
This work is licensed under a Creative Commons Attribution 4.0 International License.
The articles published in this journal come under creative commons licence Attribution 4.0 International (CC BY 4.0) which allows to copy and redistribute the material in any medium or format Adapt — remix, transform, and build upon the material for any purpose, even commercially under following terms.
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
The editorial board of the Journal strives hard for the authenticity and accuracy of the material published in the Journal. However, findings and statements are views of the authors and do not necessarily represent views of the Editorial Board. Many software like (Google Maps, Google Earth, Biorender (free version)) restricts the free distribution of materials prepared using these softwares. Therefore, authors are strongly advised to check the license/copyright information of the software used to prepare maps/images. In case of publication of copyright material, the correction will be published in one of the subsequent issues of the Journal, and the authors will bear the printing cost.
